Table 2:
Effect of MSC Administration in Ischemically Damaged Human Kidneys
Pretreatment | Posttreatment* (% Change) | |||||
---|---|---|---|---|---|---|
MSC Infusion | MAP (mmHg) |
Flow (cc/min) |
O2 Consumption (cc/min/g) |
MAP (mmHg) |
Flow (cc/min) |
O2 Consumption (cc/min/g) |
.25 × 108 | 27.7 | 113 | 0.15 | −7.8 ↓ | 23.6 ↑ | 42.3 ↑ |
.5 × 108 | 27.7 | 153 | 0.11 | −6.4 ↓ | 25.0 ↑ | 38.9 ↑ |
.75 × 108 | 34.0 | 179 | 0.09 | − 4.1↓ | 3.24 ↑ | 55.0 ↑ |
1.0 × 108 | 34.0 | 150 | 0.11 | −14.6↓ | 28.6 ↑ | 21.4 ↑ |
2.0 × 108 | 27.7 | 95 | 0.15 | 34.1↑ | 21.8 ↓ | −66.7 ↓ |
N=2 for each dose of MSC
MAP = Mean Arterial Pressure
at 24 hours of warm perfusion
+